Chris advises on a wide range of corporate transactions, including mergers & acquisitions, disposals, investments (both private equity and venture capital), corporate reorganisations and general corporate advisory work.

He works across a number of Osborne Clarke's industry sectors, with particular interest in the life sciences and health care and tech, media and comms sectors.

His clients include companies, institutional investors and management teams, across a range of industry sectors.

Chris previously completed a secondment with a major telecoms company.

Having trained at Osborne Clarke, Chris qualified as a solicitor in March 2022.



Advised the shareholders of OnePLM on the sale of OnePLM, a value-added reseller (VAR) of Siemens CAD/CAM and Product Lifecyle Management (PLM) software, to the European Digital Transformation consortium.

Synergy Retail Support

Advised the shareholders of industry-leading third party logistics (3PL) and fulfilment specialists Synergy Retail Support Ltd on the sale of a majority equity stake to a London-based private investment company.

Advent Life Sciences

Advised Advent Life Sciences, one of the leading transatlantic venture investors building innovative life sciences businesses, on its lead investment in global health technology platform, Proximie's US$80 million Series C equity financing.